US presidential candidates urged to support health research

Volume 387, Number 10037

18 June 2016

WORLD REPORT Advocates for medical research are eager to hear how the presidential candidates would advance the search for new treatments. Susan Jaffe, The Lancet’s Washington correspondent, reports.

As the most tumultuous presidential primary season in recent times comes to an end, biomedical researchers, physicians, and advocacy groups want the candidates campaigning for the White House to address some of the substantive matters they worry about: National Institutes of Health (NIH) funding, advancing Alzheimer’s disease research, speeding up drug development, and a host of research related issues.

… In New Hampshire last year, the campaigns provided a preview of the kind of discussion between candidates and voters that research and patients’ advocacy groups would like. It revealed a stark difference between Clinton and Trump on funding for Alzheimer’s research and support for those caring for the 5·4 million Americans stricken with the disease. [Continued here]

Appeals, Medicare costs, Observation care

Medicare Releases Draft Proposal For Patient Observation Notice

By Susan Jaffe | KAISER HEALTH NEWS | June 15, 2016 |This story also ran in

In just two months, a federal law kicks in requiring hospitals to tell their Medicare patients if they have not been formally admitted and why. But some physician, hospital and consumer representatives say a notice drafted by Medicare for hospitals to use may not do the job.

The law draft obs notice 061517 was a response to complaints from Medicare patients who were surprised to learn that although they had spent a few days in the hospital, they were there for observation and were not admitted. Observation patients are considered too sick to go home yet not sick enough to be admitted. They may pay higher charges than admitted patients and do not qualify for Medicare’s nursing home coverage.

The NOTICE Act requires that starting Aug. 6, Medicare patients receive a form written in “plain language” after 24 hours of observation care but no later than 36 hours. Under the law, it must explain the reason they have not been admitted and how that decision will affect Medicare’s payment for services and patients’ share of the costs. The information must also be provided verbally, and a doctor or hospital staff member must be available to answer questions

And patients could have questions, said Brenda Cude, a National Association of Insurance Commissioners consumer representative and professor of consumer economics at the University of Georgia. She said the notice is written for a 12th-grade reading level, even though most consumer materials aim for no more than an eighth-grade level. It “assumes some health insurance knowledge that we are fairly certain most people don’t have.”

…The form does not meet the expectations of Rep. Lloyd Doggett, D-Texas, who co-sponsored the law. “I am concerned that the proposed notice fulfills neither the spirit nor the letter of the law,” Doggett said in an interview. [Continuted at Kaiser Health News or USA Today]

Appeals, Medicare costs

Medicare’s Efforts To Curb Backlog Of Appeals Not Sufficient, GAO Reports

By Susan Jaffe | Kaiser Health News | June 10, 2016

Despite interventions by Medicare officials, the number of appeals from health care providers and patients Growing Wait Time1 challenging denied claims continues to spiral, increasing the backlog of cases and delaying many decisions well beyond the timeframes set by law, according to a government study released Thursday.

The report from the Government Accountability Office, said the backlog “shows no signs of abating.” It called for the Department of Health and Human Services to improve its oversight of the process and to streamline appeals so that prior decisions are taken into account and repetitive claims are handled more efficiently.

HHS officials have acknowledged the problem. Although a judge is required to issue a decision within 90 days, the average time from hearing request to decision is slightly more than two years, Nancy Griswold, the chief administrative law judge of the Office of Medicare Hearings and Appeals, said in an interview.

Requests for hearings increased “so dramatically and so quickly over the past four or five years — during a period of time when our adjudication capacity was not able to keep up for funding reasons — we were drowning” in appeals, she said. “It is not quite as bad right now, but we are unable to keep up with [those] that are coming in the door.” [Continued]

Long term care, Medicare costs

Medicare returning to an old-fashioned idea: house calls

By Susan Jaffe, Kaiser Health News | May 21, 2016 | and also published in

Looking for ways to save money and improve care, Medicare officials are returning to an old-fashioned idea: house calls.

But the experiment, called Independence at Home, is more than a nostalgic throwback to the way medicine was practiced decades ago when the doctor arrived at the patient’s door carrying a big black bag. Done right and paid right, house calls could prove to be a better way of treating very sick, elderly patients while they can still live at home. …By all accounts, saving any money on these patients is a surprise. Independence at Home targets patients with complicated chronic health problems and disabilities who are among the most expensive Medicare beneficiaries. [Continued in USA Today, Kaiser Health News, The Washington Post, or Next Avenue]

Drugs, FDA, Health IT, The Lancet

Biden Pleads for Open Data for Cancer Moonshot

Susan Jaffe | Washington Correspondent for The Lancet | 10th May 2016

Three months after Vice President Joe Biden convened the first meeting of the Cancer Moonshot Task Force—aimed at accelerating cancer prevention, treatment and cures—he pleaded for help from people who know how to marshal massive amounts of health data to create successful businesses, or apps that can guide consumers to the best hospitals. [continued here]

CDC, Drugs, Global Health, NIH, The Lancet

US responds to increase in Zika cases

Volume 387, Number 10030

30 April 2016

WORLD REPORT Health officials pursue Zika research and prepare to combat a formidable foe—the mosquito— despite uncertain funding. **Susan Jaffe, The Lancet’s Washington correspondent, reports.**

Anthony Fauci

As the number of confirmed cases of people who have contracted the Zika virus increases across the globe, the growing knowledge about this once rare infection is not reassuring. “The more we learn, the more we get concerned”, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases….

Representative Tom Cole, the Oklahoma Republican who is chairman of the House appropriations health subcommittee, said its questions about [President Barack Obama’s $1.9 billion Zika emergency funding] request are not unreasonable….“Let us do our job to make sure we do this as prudently as possible and we will get there”, he said. “Nobody thinks this is not a serious challenge”….

While clinical research and the funding debate continues, protection from the Zika virus will depend largely on avoiding the mosquitoes that carry it….

After years of cuts in federal and local funding for mosquito control, Zika is “a pretty major wake up call to rebuild those capacities”, said Lyle Petersen, director of CDC’s division of vector-borne infectious diseases. The virus is the latest “major pathogen that has come into the Americas” in recent years—after chikungunya, dengue fever, and West Nile virus—“and it won’t be the last.” [continued here] [listen to podcast here]

EPA, Global Health, The Lancet

Paris Climate Change agreement to be signed in New York

Susan Jaffe | Washington Correspondent for The Lancet | 19th April 2016

Secretary of State John Kerry will join world leaders at the United Nations headquarters in New York on April 22 to sign the landmark Paris Climate Change agreement, aimed at controlling greenhouse gases and preventing what many scientists believe would be the harmful effects of global warming.

Representatives of some 155 countries are expected at the signing ceremony, including President François Hollande of France, Canadian Prime Minister Justin Trudeau and other heads of state. …UN Secretary-General Ban Ki-moon has urged all countries to ratify the agreement as soon as possible. “It is in their national interest to implement the agreement and reap the benefits of sustainable global climate action,” he said in an email to The Lancet.

…When 55 countries responsible for at least 55 percent of global emissions do so, the agreement takes effect. That could happen this year said UN spokeswoman Devi Palanivelu, noting that several countries are coming to New York with ratification documents they will submit after signing the agreement. But things are not moving as swiftly in the U.S. [Continued here]

Affordable Care Act, Drugs, The Lancet

US election: what are the candidates’ health-care pledges?

Volume 387, Number 10026

2 April 2016

WORLD REPORT Democrats vying for their party’s presidential nomination have more detailed health-care plans than their Republican counterparts. **Susan Jaffe, The Lancet’s Washington correspondent, reports.**

Billionaire real estate developer Donald Trump’s unorthodox campaign to become the Republican presidential nominee has dominated the 2016 political race, nearly overshadowing some unconventional contenders on the Democratic side. The result is a political season that has defied the odds makers.

Former US Secretary of State and Senator from New York, Democrat Hillary Clinton may be well on her way to becoming the first woman in US history to win her party’s nomination for president. Vermont Senator Bernie Sanders, a self-proclaimed socialist, is trailing Clinton in the number of delegates needed to win the nomination. Yet his popular call for “a political revolution” continues to slowly raise his delegate count. [MORE]

Medicare Advantage, Medicare costs

When Medicare Advantage Drops Doctors, Some Members Can Switch Plans

By Susan Jaffe | Kaiser Health News | March 29, 2016 | This KHN story also ran on

Eliza Catchings has been seeing doctors at the Christie Clinic in central Illinois since 1957. But just after receiving this year’s WellCare Medicare Advantage member card, the insurer told her the clinic was leaving WellCare’s provider network and she would have to choose new doctors.

“I was terrified,” said Catchings, 79, who gets care for diabetes and heart problems. But she was helped by a little-noticed change in federal policy.

Medicare Advantage plans sold by private insurers are an alternative to traditional Medicare, but they cover services only from doctors, hospitals and other providers that are in the insurer’s network. Although providers are allowed to drop out of the plans any time, members can usually change only during the annual sign-up period in the fall. There are exceptions, but until recently losing a provider was not among them.

After insurers dropped hundreds of providers in 2013, the Centers for Medicare and Medicaid Services issued rules giving people a “special enrollment period” to change plans or join regular Medicare if there was a “significant” change in their provider network. The policy took effect in 2015 and applies only to Medicare Advantage members, not to the plans CMS oversees in the health law’s marketplaces. …Yet officials didn’t explain what they considered significant or what would trigger the option.

In the past eight months, Medicare officials have quietly granted the special enrollment periods to more than 15,000 Medicare Advantage members in seven states, the District of Columbia and Puerto Rico based on provider cuts. These decisions offer important details about how members can get permission to follow their doctors who leave their plans. … Medicare doesn’t publicize the option, and few beneficiaries may know about it. Representatives who answered calls earlier in March to Medicare’s toll-free number said nothing could be done. [Continued on Kaiser Health News or NPR]

CDC, Global Health, NIH, The Lancet

Zika response threatened by funding shortage

Susan Jaffe | Washington Correspondent for The Lancet | 14 March 2016

Congress hasn’t budged in the five weeks since President Barack Obama asked Congress for more than $1.8 billion in emergency funding to deal with the Zika virus. But Zika isn’t waiting.

In the weeks since the president’s request, the number of cases of the mosquito-borne virus among people who traveled to countries where transmission has been confirmed has almost quadrupled to 193, as of March 9. It is in nearly twice as many states — 32 and the District of Columbia — with Florida, New York and Texas topping the list. In Puerto Rico, the U. S. Virgin Islands, and American Samoa, the number of cases is 174, or 19 times higher, reports the US Centers for Disease Control and Prevention. [continued here]

FDA, Global Health, NIH, The Lancet

NIH hopes funding increases will continue

Volume 387, Number 10019

13 February 2016

WORLD REPORT **The US National Institutes of Health welcomed a record budget boost that might be the start of more sustained support. The Lancet’s Washington correspondent, Susan Jaffe, reports.**

The US Congress recently approved the largest single increase in funding for the National Institutes of Health (NIH) in 12 years—a US$2 billion raise that was twice as much as President Barack Obama requested. But almost as soon as NIH supporters stopped cheering, they began to worry about next year’s budget, and the challenge of a new public health threat, Zika virus.

NIH Director Francis Collins told The Lancet that the funding boost “was enormously gratifying”. But if it is “a one-hit wonder”, he said “it won’t be sufficient to take full advantage of the remarkable scientific opportunities and talent that is out there”. [Continued here] [podcast here]

CDC, FDA, Global Health, NIH, The Lancet

Congress Wrangles Over Funding for Zika Research

Susan Jaffe | Washington Correspondent for The Lancet | 12th February 2016

President Barack Obama asked Congress this week for more than $1.8 billion in emergency funding to respond to Zika virus and administration officials wasted no time in explaining why at four congressional hearings less than two days later.

While such Capitol Hill visits are part of the budget process, the looming virus adds a new urgency to the proceedings–though not necessarily enough to deter controversy. [Continued here]

Drugs, FDA, The Lancet

Shkreli pleads the Fifth on drug price hikes

Susan Jaffe | Washington Correspondent for The Lancet | 10th February 2016

Like many Americans, members of Congress are frustrated and angry about the huge spikes in prescription drug prices. While a congressional hearing held last week to investigate the practice united Democrats and Republicans in outrage, it did not reveal potential solutions.

The unwilling star witness was Martin Shkreli, the former head of Turing Pharmaceuticals who was responsible for the company’s decision to raise the price of Daraprim, used to treat toxoplasmosis, a parasitic infection that affects HIV patients, from $13.50 to $750 a pill. [Continued here]

Drugs, Long term care, Medicare costs, Medigap

Buying Supplemental Insurance Can Be Hard For Younger Medicare Beneficiaries

By Susan Jaffe | February 3, 2016 | Kaiser Health News in collaboration with Money magazine

Danny Thompson’s kidneys have failed and he needs a transplant but in some ways, he’s lucky: Both of his sons want to give him one of theirs, and his Medicare coverage will take care of most his expenses.

Danny Thompson (Heidi de Marco/KHN)

Yet the 53-year-old Californian is facing another daunting obstacle: He doesn’t

have the money for his share of the medical bills and follow-up drugs, and he can’t buy supplemental insurance to help cover his costs.

“It’s frustrating to be in the shape I’m in,” said Thompson, who depends on dialysis instead of his kidneys to cleanse his blood. “My plan is to get a transplant so I can go back to work.”

Almost one in four Medicare beneficiaries has such a policy, known as Medigap, which is sold by private insurance companies. It can help pay for costs Medicare doesn’t cover, including the 20 percent coinsurance required for medical expenses, including certain drugs, plus deductibles and co-payments. Those expenses have no out-of-pocket limit for beneficiaries.

This KHN story also ran on Money.

Federal law requires companies to sell Medigap plans to any Medicare beneficiary aged 65 or older within six months of signing up for Part B, which covers doctor visits and other outpatient services. If they sign up during this guaranteed open enrollment, they cannot be charged higher premiums due to their medical conditions.

But Congress left it to states to determine whether Medigap plans are sold to the more than 9 million people younger than 65 years old who qualify for Medicare because of a disability. [Continued in Kaiser Health News or Money magazine.]

Long term care, Medicare costs

Hospitals Step Up To Help Seniors Avoid Falls

By Susan Jaffe | Kaiser Health News | January 12, 2016 This KHN story also ran in

Falls are the leading cause of injuries for adults 65 and older, and 2.5 million of them end up in hospital emergency departments for treatment every year, according to the Centers for Disease Control and Prevention. The consequences can range from bruises, fractured hips and head injuries to irreversible calamities that can lead to death.

Despite these scary statistics, a dangerous fall does not have to be an inevitable part of aging. Risk-reduction programs are offered around the country, including several at hospitals in the Washington area. [Full article from Kaiser Health News and The Washington Post] [Watch video of balance training class]

Page 14 of 23

« 1 … 12 13 14 15 16 … 23 »